Andreu Òdena

发表论文 12 篇 · 总被引 170 次 · h-index 5

代表论文

High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer (2021 · Nature Communications · 被引 92)
Genetic alterations in the PI3K/AKT pathway and baseline AKT activity define AKT inhibitor sensitivity in breast cancer patient-derived xenografts (2020 · Clinical Cancer Research · 被引 26)
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response (2024 · Nature Communications · 被引 25)
Enhancing CHO cell productivity through a dual selection system using Aspg and Gs in glutamine free medium (2022 · Biotechnology and Bioengineering · 被引 19)
Harnessing STING Signaling and Natural Killer Cells overcomes PARP Inhibitor Resistance in Homologous Recombination Deficient Breast Cancer. (2025 · Cancer Research · 被引 17)
Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer (2022 · Nature Communications · 被引 4)